[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Bevacizumab Biosimilar Sales Market Report Forecast 2017 to 2022

November 2017 | 119 pages | ID: G032ED8D3C7EN
S&P Consulting

US$ 3,040.00 US$ 3,800.00 -20 %

E-mail Delivery (PDF), E-mail Delivery (Word), E-mail Delivery (Excel), E-mail Delivery (PowerPoint)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Delivery of the Report will take 2-3 working days once order is placed.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:
Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals

Product Segment Analysis:
Type 1
Type 2
Type 3

Application Segment Analysis:
Application 1
Application 2
Application 3

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

It provides distinctive graphics and exemplified analysis of major market segments
1 BEVACIZUMAB BIOSIMILAR MARKET OVERVIEW

1.1 Product Overview and Scope of Bevacizumab Biosimilar
1.2 Classification of Bevacizumab Biosimilar
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Bevacizumab Biosimilar
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Bevacizumab Biosimilar Market States Status and Prospect (2012-2022) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Bevacizumab Biosimilar (2012-2022)
  1.5.1 Global Bevacizumab Biosimilar Sales and Growth Rate (2012-2022)
  1.5.2 Global Bevacizumab Biosimilar Revenue and Growth Rate (2012-2022)

2 GLOBAL ECONOMIC IMPACT ON BEVACIZUMAB BIOSIMILAR INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 BEVACIZUMAB BIOSIMILAR MANUFACTURING COST ANALYSIS

3.1 Bevacizumab Biosimilar Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Bevacizumab Biosimilar

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Bevacizumab Biosimilar Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Bevacizumab Biosimilar Major Manufacturers in 2016
4.4 Downstream Buyers

5 GLOBAL BEVACIZUMAB BIOSIMILAR COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Bevacizumab Biosimilar Market Competition by Manufacturers
  5.1.1 Global Bevacizumab Biosimilar Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Bevacizumab Biosimilar Revenue and Share by Manufacturers (2012-2017)
5.2 Global Bevacizumab Biosimilar (Volume and Value) by Type
  5.5.1 Global Bevacizumab Biosimilar Sales and Market Share by Type (2012-2017)
  5.5.2 Global Bevacizumab Biosimilar Revenue and Market Share by Type (2012-2017)
5.3 Global Bevacizumab Biosimilar (Volume and Value) by Regions
  5.3.1 Global Bevacizumab Biosimilar Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Bevacizumab Biosimilar Revenue and Market Share by Regions (2012-2017)
5.4 Global Bevacizumab Biosimilar (Volume) by Application

6 UNITED STATES BEVACIZUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

6.1 United States Bevacizumab Biosimilar Sales and Value (2012-2017)
  6.1.1 United States Bevacizumab Biosimilar Sales and Growth Rate (2012-2017)
  6.1.2 United States Bevacizumab Biosimilar Revenue and Growth Rate (2012-2017)
  6.1.3 United States Bevacizumab Biosimilar Sales Price Trend (2012-2017)
6.2 United States Bevacizumab Biosimilar Sales and Market Share by Manufacturers
6.3 United States Bevacizumab Biosimilar Sales and Market Share by Type
6.4 United States Bevacizumab Biosimilar Sales and Market Share by Application

7 CHINA BEVACIZUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

7.1 China Bevacizumab Biosimilar Sales and Value (2012-2017)
  7.1.1 China Bevacizumab Biosimilar Sales and Growth Rate (2012-2017)
  7.1.2 China Bevacizumab Biosimilar Revenue and Growth Rate (2012-2017)
  7.1.3 China Bevacizumab Biosimilar Sales Price Trend (2012-2017)
7.2 China Bevacizumab Biosimilar Sales and Market Share by Manufacturers
7.3 China Bevacizumab Biosimilar Sales and Market Share by Type
7.4 China Bevacizumab Biosimilar Sales and Market Share by Application

8 EUROPE BEVACIZUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Bevacizumab Biosimilar Sales and Value (2012-2017)
  8.1.1 Europe Bevacizumab Biosimilar Sales and Growth Rate (2012-2017)
  8.1.2 Europe Bevacizumab Biosimilar Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Bevacizumab Biosimilar Sales Price Trend (2012-2017)
8.2 Europe Bevacizumab Biosimilar Sales and Market Share by Manufacturers
8.3 Europe Bevacizumab Biosimilar Sales and Market Share by Type
8.4 Europe Bevacizumab Biosimilar Sales and Market Share by Application

9 JAPAN BEVACIZUMAB BIOSIMILAR (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Bevacizumab Biosimilar Sales and Value (2012-2017)
  9.1.1 Japan Bevacizumab Biosimilar Sales and Growth Rate (2012-2017)
  9.1.2 Japan Bevacizumab Biosimilar Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Bevacizumab Biosimilar Sales Price Trend (2012-2017)
9.2 Japan Bevacizumab Biosimilar Sales and Market Share by Manufacturers
9.3 Japan Bevacizumab Biosimilar Sales and Market Share by Type
9.4 Japan Bevacizumab Biosimilar Sales and Market Share by Application

10 GLOBAL BEVACIZUMAB BIOSIMILAR MANUFACTURERS ANALYSIS

10.1 Pfizer
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Allergan
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Alnylam Pharmaceuticals
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Amgen
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Angstrom Pharmaceuticals
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Acceleron Pharma
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Biocon
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Bionomics
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 CASI Pharmaceuticals
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL BEVACIZUMAB BIOSIMILAR MARKET FORECAST (2017-2022)

13.1 Global Bevacizumab Biosimilar Sales, Revenue Forecast (2017-2022)
13.2 Global Bevacizumab Biosimilar Sales Forecast by Regions (2017-2022)
13.3 Global Bevacizumab Biosimilar Sales Forecast by Type (2017-2022)
13.4 Global Bevacizumab Biosimilar Sales Forecast by Application (2017-2022)

14 APPENDIX


LIST OF TABLES AND FIGURES

Figure Picture of Bevacizumab Biosimilar
Table Classification of Bevacizumab Biosimilar
Figure Global Sales Market Share of Bevacizumab Biosimilar by Type in 2016
Table Applications of Bevacizumab Biosimilar
Figure Global Sales Market Share of Bevacizumab Biosimilar by Application in 2016
Figure United States Bevacizumab Biosimilar Revenue and Growth Rate (2012-2022)
Figure China Bevacizumab Biosimilar Revenue and Growth Rate (2012-2022)
Figure Europe Bevacizumab Biosimilar Revenue and Growth Rate (2012-2022)
Figure Japan Bevacizumab Biosimilar Revenue and Growth Rate (2012-2022)
Figure Global Bevacizumab Biosimilar Sales and Growth Rate (2012-2022)
Figure Global Bevacizumab Biosimilar Revenue and Growth Rate (2012-2022)
Table Global Bevacizumab Biosimilar Sales of Key Manufacturers (2012-2017)
Table Global Bevacizumab Biosimilar Sales Share by Manufacturers (2012-2017)
Figure 2015 Bevacizumab Biosimilar Sales Share by Manufacturers
Figure 2016 Bevacizumab Biosimilar Sales Share by Manufacturers
Table Global Bevacizumab Biosimilar Revenue by Manufacturers (2012-2017)
Table Global Bevacizumab Biosimilar Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Bevacizumab Biosimilar Revenue Share by Manufacturers
Table 2016 Global Bevacizumab Biosimilar Revenue Share by Manufacturers
Table Global Bevacizumab Biosimilar Sales and Market Share by Type (2012-2017)
Table Global Bevacizumab Biosimilar Sales Share by Type (2012-2017)
Figure Sales Market Share of Bevacizumab Biosimilar by Type (2012-2017)
Figure Global Bevacizumab Biosimilar Sales Growth Rate by Type (2012-2017)
Table Global Bevacizumab Biosimilar Revenue and Market Share by Type (2012-2017)
Table Global Bevacizumab Biosimilar Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Bevacizumab Biosimilar by Type (2012-2017)
Figure Global Bevacizumab Biosimilar Revenue Growth Rate by Type (2012-2017)
Table Global Bevacizumab Biosimilar Sales and Market Share by Regions (2012-2017)
Table Global Bevacizumab Biosimilar Sales Share by Regions (2012-2017)
Figure Sales Market Share of Bevacizumab Biosimilar by Regions (2012-2017)
Figure Global Bevacizumab Biosimilar Sales Growth Rate by Regions (2012-2017)
Table Global Bevacizumab Biosimilar Revenue and Market Share by Regions (2012-2017)
Table Global Bevacizumab Biosimilar Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Bevacizumab Biosimilar by Regions (2012-2017)
Figure Global Bevacizumab Biosimilar Revenue Growth Rate by Regions (2012-2017)
Table Global Bevacizumab Biosimilar Sales and Market Share by Application (2012-2017)
Table Global Bevacizumab Biosimilar Sales Share by Application (2012-2017)
Figure Sales Market Share of Bevacizumab Biosimilar by Application (2012-2017)
Figure Global Bevacizumab Biosimilar Sales Growth Rate by Application (2012-2017)
Figure United States Bevacizumab Biosimilar Sales and Growth Rate (2012-2017)
Figure United States Bevacizumab Biosimilar Revenue and Growth Rate (2012-2017)
Figure United States Bevacizumab Biosimilar Sales Price Trend (2012-2017)
Table United States Bevacizumab Biosimilar Sales by Manufacturers (2012-2017)
Table United States Bevacizumab Biosimilar Market Share by Manufacturers (2012-2017)
Table United States Bevacizumab Biosimilar Sales by Type (2012-2017)
Table United States Bevacizumab Biosimilar Market Share by Type (2012-2017)
Table United States Bevacizumab Biosimilar Sales by Application (2012-2017)
Table United States Bevacizumab Biosimilar Market Share by Application (2012-2017)
Figure China Bevacizumab Biosimilar Sales and Growth Rate (2012-2017)
Figure China Bevacizumab Biosimilar Revenue and Growth Rate (2012-2017)
Figure China Bevacizumab Biosimilar Sales Price Trend (2012-2017)
Table China Bevacizumab Biosimilar Sales by Manufacturers (2012-2017)
Table China Bevacizumab Biosimilar Market Share by Manufacturers (2012-2017)
Table China Bevacizumab Biosimilar Sales by Type (2012-2017)
Table China Bevacizumab Biosimilar Market Share by Type (2012-2017)
Table China Bevacizumab Biosimilar Sales by Application (2012-2017)
Table China Bevacizumab Biosimilar Market Share by Application (2012-2017)
Figure Europe Bevacizumab Biosimilar Sales and Growth Rate (2012-2017)
Figure Europe Bevacizumab Biosimilar Revenue and Growth Rate (2012-2017)
Figure Europe Bevacizumab Biosimilar Sales Price Trend (2012-2017)
Table Europe Bevacizumab Biosimilar Sales by Manufacturers (2012-2017)
Table Europe Bevacizumab Biosimilar Market Share by Manufacturers (2012-2017)
Table Europe Bevacizumab Biosimilar Sales by Type (2012-2017)
Table Europe Bevacizumab Biosimilar Market Share by Type (2012-2017)
Table Europe Bevacizumab Biosimilar Sales by Application (2012-2017)
Table Europe Bevacizumab Biosimilar Market Share by Application (2012-2017)
Figure Japan Bevacizumab Biosimilar Sales and Growth Rate (2012-2017)
Figure Japan Bevacizumab Biosimilar Revenue and Growth Rate (2012-2017)
Figure Japan Bevacizumab Biosimilar Sales Price Trend (2012-2017)
Table Japan Bevacizumab Biosimilar Sales by Manufacturers (2012-2017)
Table Japan Bevacizumab Biosimilar Market Share by Manufacturers (2012-2017)
Table Japan Bevacizumab Biosimilar Sales by Type (2012-2017)
Table Japan Bevacizumab Biosimilar Market Share by Type (2012-2017)
Table Japan Bevacizumab Biosimilar Sales by Application (2012-2017)
Table Japan Bevacizumab Biosimilar Market Share by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Bevacizumab Biosimilar Global Market Share (2012-2017)
Table Allergan Basic Information List
Table Allergan Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Allergan Bevacizumab Biosimilar Global Market Share (2012-2017)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Alnylam Pharmaceuticals Bevacizumab Biosimilar Global Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Bevacizumab Biosimilar Global Market Share (2012-2017)
Table Angstrom Pharmaceuticals Basic Information List
Table Angstrom Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Angstrom Pharmaceuticals Bevacizumab Biosimilar Global Market Share (2012-2017)
Table Acceleron Pharma Basic Information List
Table Acceleron Pharma Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Acceleron Pharma Bevacizumab Biosimilar Global Market Share (2012-2017)
Table Biocon Basic Information List
Table Biocon Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biocon Bevacizumab Biosimilar Global Market Share (2012-2017)
Table Bionomics Basic Information List
Table Bionomics Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bionomics Bevacizumab Biosimilar Global Market Share (2012-2017)
Table CASI Pharmaceuticals Basic Information List
Table CASI Pharmaceuticals Bevacizumab Biosimilar Sales, Revenue, Price and Gross Margin (2012-2017)
Figure CASI Pharmaceuticals Bevacizumab Biosimilar Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bevacizumab Biosimilar
Figure Manufacturing Process Analysis of Bevacizumab Biosimilar
Figure Bevacizumab Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Bevacizumab Biosimilar Major Manufacturers in 2016
Table Major Buyers of Bevacizumab Biosimilar
Table Distributors/Traders List
Figure Global Bevacizumab Biosimilar Sales and Growth Rate Forecast (2017-2022)
Figure Global Bevacizumab Biosimilar Revenue and Growth Rate Forecast (2017-2022)
Table Global Bevacizumab Biosimilar Sales Forecast by Regions (2017-2022)
Table Global Bevacizumab Biosimilar Sales Forecast by Type (2017-2022)
Table Global Bevacizumab Biosimilar Sales Forecast by Application (2017-2022)

COMPANIES MENTIONED

Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals
Celgene Corporation
Enzon Pharmaceuticals
Five Prime Therapeutics
Fujifilm Kyowa Kirin Biologics
Genentech
Genexine
Hetero Drugs
ImClone Systems
Intas Pharmaceuticals
Kyowa Hakko Kirin
Levolta Pharmaceuticals
Mabtech
Marsala Biotech
Neumedicines
Novartis
Oncobiologics
Onyx Pharmaceuticals


More Publications